Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04292730
Other study ID # GS-US-540-5774
Secondary ID 2020-000842-32IS
Status Completed
Phase Phase 3
First received
Last updated
Start date March 15, 2020
Est. completion date June 26, 2020

Study information

Verified date January 2021
Source Gilead Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study was to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.


Recruitment information / eligibility

Status Completed
Enrollment 1113
Est. completion date June 26, 2020
Est. primary completion date April 29, 2020
Accepts healthy volunteers No
Gender All
Age group 12 Years and older
Eligibility Key Inclusion Criteria: - Willing and able to provide written informed consent prior to performing study procedures (participants = 18 years of age) or assent (participants = 12 and < 18 years of age) prior to performing study procedures. For participants = 12 and < 18 years of age, a parent or legal guardian willing and able to provide written informed consent prior to performing study procedures - Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test = 4 days before randomization - Currently hospitalized and requiring medical care for COVID-19 - Peripheral capillary oxygen saturation (SpO2) > 94% on room air at screening - Radiographic evidence of pulmonary infiltrates Key Exclusion Criteria: - Participation in any other clinical trial of an experimental treatment for COVID-19 - Concurrent treatment or planned concurrent treatment with other agents with actual or possible direct acting antiviral activity against SARS-CoV-2 - Requiring mechanical ventilation at screening - Alanine Aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 X upper limit of normal (ULN) - Creatinine clearance < 50 mL/min using the Cockcroft-Gault formula for participants = 18 years of age {Cockcroft 1976} and Schwartz Formula for participants < 18 years of age Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Remdesivir
Administered as an intravenous infusion
Standard of Care
Standard of Care Treatment for COVID-19 Infection

Locations

Country Name City State
China The First Affiliated Hospital of Guangzhou Medical University Guangzhou
France CHU Pellegrin Bordeaux
France CHU de Montpellier-Hopital Gui de Chauliac Montpelier Cedex 5
France CHU de Nantes-Hotel Dieu Nantes
France Hopital Saint Antoine Paris
France Hopital Saint-Louis Paris
Germany Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik Infektiologie Pneumologie Berlin
Germany Universitatsklinikum Dusseldorf, Klinik fur Gastroenterologie, Hepatologie und Infektiologie Düsseldorf
Germany Universitatsklinikum Hamburg-Eppendorf Hamburg
Germany Universitätsklinikum Schleswig-Holstein Campus Kiel Kiel
Germany Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie Leipzig
Germany Klinik für Hämatologie, Onkologie, Immunologie München
Germany Klinikum rechts der Isar der TU Munchen, Klinik und Poliklinik Innere Medizin 2 Munich
Germany Robert-Bosch-Krankenhaus (RBK), Klinik Schillerhohe (KSH) und Dr. Margarete Fischer-Bosch-Institut fur klinische Pharmakologie (IKP) Stuttgart
Hong Kong Prince of Wales Hospital Hong Kong
Hong Kong Princess Margaret Hospital Hong Kong
Hong Kong Queen Mary Hospital Hong Kong
Italy UOC Malattie Infettive, ASST Papa Giovanni XXIII Bergamo
Italy ASST degli Spedali Civili di Brescia Brescia
Italy ASST di Cremona - Azienda Socio Sanitaria Territor Cremona
Italy UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan
Italy ASST Fatebenefratelli Sacco Milano
Italy UOC Malattie Infettive, IRCCS Ospedale San Raffaele Milano
Italy UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova Padova PD
Italy Azienda Ospedaliero Universitaria di Parma Parma
Italy Malattie Infettive I, Fondazione IRCCS Policlinico San Matteo Pavia
Italy Ospedale Guglielmo da Saliceto AUSL di Piacenza Piacenza
Italy UOC Malattie Infettive ad Alta Intensita di Cure, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S. Roma
Italy Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia Torino
Japan Yokohama Municipal Citizen's Hospital Kanagawa
Japan Nagoya City East Medical Center Nagoya
Japan Tokyo Metropolitan Bokutoh Hospital Tokyo
Korea, Republic of Kyungpook National University Hospital Daegu
Korea, Republic of National Medical Center Seoul
Korea, Republic of Seoul Medical Center Seoul
Netherlands Amsterdam University Medical Centre - Location AMC Amsterdam
Netherlands Leiden University Medical Center Leiden
Netherlands Erasmus Medical Centre Rotterdam
Singapore National Centre for Infectious Diseases, Tan Tock Seng Hospital Singapore
Singapore National University Hospital Singapore
Singapore Singapore General Hospital Singapore
Spain Complejo Hospitalario Universitario A Coruña A Coruña
Spain Hospital Principe de Asturias Alcalá De Henares Madrid
Spain Hospital Clinic de Barcelona Barcelona
Spain Hospital Universitari de Bellvitge Barcelona
Spain Hospital Universitario Vall d'Hebron Barcelona
Spain Hospital Universitario Cruces Bizkaia
Spain Hospital Universitario 12 de Octubre Madrid
Spain Hospital Universitario Fundación Jiménez Díaz Madrid
Spain Hospital Universitario La Paz Madrid
Spain Hospital Universitario Ramón y Cajal Madrid
Spain Hospital Regional Universitario de Málaga Málaga
Spain Hospital Universitario Virgen del Rocio Sevilla
Spain Hospital Universitari i Politecnic La Fe Valencia
Sweden Sahlgrenska University Hospital, Ostra Gothenburg
Sweden SUS (Skanes University Hospital) Malmo
Sweden Karolinska University Hospital Stockholm
Switzerland Hopitaux Universitaires de Genève Genève 14
Switzerland Ospedale Regionale di Locarno La Carità Lugano
Switzerland Universitätsspital Zürich Zürich
Taiwan Kaohsiung Veterans General Hospital Kaohsiung
Taiwan China Medical University Hospital Taichung
Taiwan National Taiwan University Hospital Taipei City
United Kingdom NHS Lothian, Royal lnfirmary of Edinburgh Edinburgh
United Kingdom Queen Elizabeth University Hospital Glasgow
United Kingdom Hull University Teaching Hospitals NHS Trust Hull
United Kingdom Royal Lancaster Hospital Lancaster
United Kingdom Liverpool University Hospital Liverpool
United Kingdom Imperial College NHS Trust London Greater London
United Kingdom King's College Hospital NHS Trust London
United Kingdom Northwick Park Hospital London
United Kingdom Royal Free London NHS Foundation Trust London
United Kingdom University College London London
United Kingdom Manchester University NHS Foundation Trust Manchester
United Kingdom Manchester University NHS Foundation Trust Manchester
United Kingdom Pennine Acute Hospitals NHS Trust Manchester
United Kingdom Derriford Hospital Plymouth
United Kingdom Sheffield Teaching Hospitals Sheffield
United States Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue Anaheim California
United States The University of Michigan Hospitals and Health Systems Ann Arbor Michigan
United States Virginia Hospital Center Arlington Virginia
United States University of Colorado Denver, University of Colorado Hospital Aurora Colorado
United States Alta Bates Summit Medical Center Berkeley California
United States Brigham & Women's Hospital and Harvard Medical School Boston Massachusetts
United States Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Boston Massachusetts
United States Tufts Medical Center Boston Massachusetts
United States Jacobi Medical Center Bronx New York
United States James J. Peters Veterans Administration Medical Center Bronx New York
United States Mills-Peninsula Medical Center Burlingame California
United States Eden Medical Center Castro Valley California
United States Cook County General Hospital Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States University of Chicago Chicago Illinois
United States University Hospitals Cleveland Medical Center Cleveland Ohio
United States Prisma Health Richland Hospital Columbia South Carolina
United States Baylor University Medical Center Dallas Texas
United States The Liver Institute of Methodist Dallas Medical Center Dallas Texas
United States UT Southwestern Medical Center Amelia Court, HIV Research Clinic Dallas Texas
United States UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd. Dallas Texas
United States UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd Dallas Texas
United States Rose Medical Center Denver Colorado
United States SCL Health St. Joseph Hospital Denver Colorado
United States SCL Health St. Joseph Hospital, 1375 East 19th Ave Denver Colorado
United States Henry Ford Health System Detroit Michigan
United States Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway Downey California
United States Duke University Medical Center Durham North Carolina
United States Providence Medical Research Center Everett Washington
United States Inova Fairfax Hospital Falls Church Virginia
United States Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave Fontana California
United States Baylor University Medical Center, 1400 8th Ave Fort Worth Texas
United States St Joseph Hospital Eureka Fortuna California
United States Prisma Health Richland Hospital, 701 Grove Road Greenville South Carolina
United States Hackensack Medical Center Hackensack New Jersey
United States Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave. Harbor City California
United States Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave Hillsboro Oregon
United States Robert Wood Johnson University Hospital Somerset Hillsborough New Jersey
United States Kaiser Permanente Hawaii Moanalua Medical Center Honolulu Hawaii
United States Houston Methodist Hospital Houston Texas
United States IU Health Methodist Hospital Indianapolis Indiana
United States University of Iowa Hospitals & Clinics Iowa City Iowa
United States Jamaica Hospital Medical Center Jamaica New York
United States Kadlec Regional Medical Center Kennewick Washington
United States SCL Health St. Joseph Hospital, 200 Exempla Circle. Lafayette Colorado
United States Danbury Hospital Lagrangeville New York
United States Darmouth-Hitchhock Medical Center Lebanon New Hampshire
United States Kaiser Permanente Los Angeles Medical Center Los Angeles California
United States Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue Los Angeles California
United States Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave. Los Angeles California
United States North Shore University Hospital Manhasset New York
United States Hennepin Healthcare Minneapolis Minnesota
United States Mission Hospital Regional Medical Center Mission Viejo California
United States Providence St Patrick Hospital and International Heart Institute of MT Foundation Missoula Montana
United States Kaiser Permanente Los Angeles Medical Center,27300 Iris Avenue Moreno Valley California
United States El Camino Hospital Mountain View California
United States Robert Wood Johnson University Hospital Somerset, 1 RWJ Place New Brunswick New Jersey
United States Yale University New Haven Connecticut
United States North Shore University Hospital, 270-05 76th Ave New Hyde Park New York
United States Tulane University New Orleans Louisiana
United States Columbia University Irving Medical Center New York New York
United States Icahn School of Medicine at Mount Sinai New York New York
United States Icahn School of Medicine at Mount Sinai, 1000 10th Avenue New York New York
United States Icahn School of Medicine at Mount Sinai, 350 East 17th Street New York New York
United States Icahn School of Medicine at Mount Sinai, 440 West 114th St. New York New York
United States Weill Cornell Medical College/NYU Presbyterian Hospital New York New York
United States Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue Newark New Jersey
United States Hoag Memorial Hospital Presbyterian Newport Beach California
United States Kaiser Permanente Oakland Medical Center Oakland California
United States Providence St. Peter Hospital Olympia Washington
United States Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue Ontario California
United States The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange Orange California
United States Kaiser Permanente Los Angeles Medical Center,13651 Willard Street Panorama City California
United States St. Joseph's University Medical Center Paterson New Jersey
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Hospital of the University of Pennsylvania, 51 N. 31st Street Philadelphia Pennsylvania
United States Temple University Hospital Philadelphia Pennsylvania
United States Kaiser Sunnyside Medical Center Portland Oregon
United States Maine Medical Center Portland Maine
United States Providence Portland Medical Center Portland Oregon
United States Providence St. Vincent Medical Center Portland Oregon
United States The Miriam Hospital Providence Rhode Island
United States VCU Health Medical Center Richmond Virginia
United States Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue Riverside California
United States Mayo Clinic Rochester Minnesota
United States Sutter Medical Center Sacramento, One Medical Plaza Roseville California
United States Sutter Medical Center Sacramento Sacramento California
United States University of Utah Health Salt Lake City Utah
United States Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue San Diego California
United States Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd San Diego California
United States California Pacific Medical Center-Infectious Disease Associates Medical Group San Francisco California
United States Kaiser Permanente Oakland Medical Center, 1200 El Camino Real San Francisco California
United States Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd San Francisco California
United States Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850 San Jose California
United States Kaiser Permanente Oakland Medical Center, 2500 Merced St San Leandro California
United States Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway Santa Clara California
United States Providence St. Johns Medical Center Santa Monica California
United States Sutter Santa Rosa Regional Hospital Santa Rosa California
United States Swedish Center for Comprehensive Care Seattle Washington
United States Virginia Mason Medical Center Seattle Washington
United States Holy Cross Hospital Silver Spring Maryland
United States MultiCare Deaconess Hospital Spokane Washington
United States Stanford Hospital Stanford California
United States MultiCare Tacoma General Hospital Tacoma Washington
United States St Joseph Medical Center Tacoma Washington
United States Baylor University Medical Center, 2401 S. 31st St. Temple Texas

Sponsors (1)

Lead Sponsor Collaborator
Gilead Sciences

Countries where clinical trial is conducted

United States,  China,  France,  Germany,  Hong Kong,  Italy,  Japan,  Korea, Republic of,  Netherlands,  Singapore,  Spain,  Sweden,  Switzerland,  Taiwan,  United Kingdom, 

References & Publications (1)

Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blai — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Part A: Percentage of Participants in Each Clinical Status Category as Assessed by a 7-Point Ordinal Scale on Day 11 Clinical status was derived from death, hospital discharge, and ordinal scale as follows: score of "1" was used for all days on or after the date of death; score of "7" was used for all days on or after discharged alive date; last available assessment for missing value. The scale is as follows: 1. Death; 2. Hospitalized, on invasive mechanical ventilation or Extracorporeal Membrane Oxygenation (ECMO); 3. Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4. Hospitalized, requiring low flow supplemental oxygen; 5. Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (coronavirus (COVID-19) related or otherwise); 6. Hospitalized, not requiring supplemental oxygen - no longer required ongoing medical care (other than per protocol remdesivir administration; 7. Not hospitalized. The odds ratio represents the odds of improvement in the ordinal scale for a RDV group relative to the SOC group. Day 11
Secondary Part A: Percentage of Participants Who Experienced Treatment-Emergent Adverse Events (TEAEs) TEAEs were defined as the following: any AE with an onset date on or after the study treatment start date and no later than 30 days after permanent discontinuation of study treatment and/or any AE leading to premature discontinuation of study treatment. For participants randomized to the SOC group, all AEs reported on or after the protocol-specified Day 1 visit were considered as treatment emergent. First dose date up to last dose date (maximum: 10 days) plus 30 days
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure